Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | XBP1 | P17861 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17138134 | 0.95 | L3MBTL1 (0.46) | L3MBTL1GAAXBP1ATMNPSR1 | |
| SCHEMBL2291004 | 0.89 | PRSS1 (0.48) | PRSS1PRSS2PRSS3CA1L3MBTL1 | |
| SCHEMBL17138165 | 0.89 | TSHR (0.44) | L3MBTL1ALDH1A1TSHRMAPK1TDP1 | |
| SCHEMBL27994629 | 0.88 | PRSS1 (0.50) | PRSS1PRSS2PRSS3CA1L3MBTL1 | |
| SCHEMBL2294692 | 0.88 | PRSS1 (0.50) | PRSS1PRSS2PRSS3CA1L3MBTL1 | |
| SCHEMBL11699133 | 0.88 | PRSS1 (0.50) | PRSS1PRSS2PRSS3CA1L3MBTL1 | |
| SCHEMBL1900961 | 0.88 | PRSS1 (0.50) | PRSS1PRSS2PRSS3CA1L3MBTL1 | |
| SCHEMBL29266799 | 0.88 | PRSS1 (0.50) | PRSS1PRSS2PRSS3CA1L3MBTL1 | |
| SCHEMBL2294967 | 0.88 | PRSS1 (0.50) | PRSS1PRSS2PRSS3CA1L3MBTL1 | |
| SCHEMBL1537155 | 0.84 | CA2 (0.48) | PRSS1PRSS2PRSS3L3MBTL1ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | RNS CO.,LTD. (KR) | 2015-10-08 | — | — | US | disclosed |
| CN-103664591-A | Novel benzendiol derivative compound and cosmetic composition utilizing the same | ACT CO LTD | 2014-03-26 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150283051-A1 | DERIVATIVE OF NOVEL POLYHYDROXY AROMATIC COMPOUND AND USE THEREOF | HRH3, CBR3, H1-0 | PRSS1 3920/4885PRSS2 4716/4885PRSS3 4481/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.